Foundry Innovation & Research 1, Limited (FIRE1) is the lead sponsor of 3 current clinical trials in our USA, Ireland and UK registers. 1 is recruiting patients now. All registered phases are Not applicable. The most-studied condition is Heart Failure.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
NORM-HF Pivotal Study
NCT07574593 · ClinicalTrials.gov ↗ · Heart Failure, NYHA Class III Heart Failure, NYHA Class II Heart Failure
|
Not applicable | Recruiting | 2026-05 | USA |
|
First in Human Clinical Investigation of the FIRE1 System in Heart Failure Patients (FUTURE-HF)
NCT04203576 · Heart Failure
|
Not applicable | Active, closed | 2019-11 | Ireland, UK |
|
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
NCT05763407 · ClinicalTrials.gov ↗ · Heart Failure
|
Not applicable | Active, closed | 2023-06 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 2 | 1 |
| Clinical trials in Ireland | 1 | 0 |
| Clinical trials in UK | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Sponsors with the most current trials registered for this condition.
Foundry Innovation & Research 1, Limited (FIRE1) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our USA, Ireland and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.